CG - Conference and earnings call announcements

Establishes Vantive as a leading standalone kidney care business backed by Carlyle's global investment team and resources Sale follows robust process focused on maximizing stockholder value Provides increased flexibility to deploy capital toward opportunities to accelerate Baxter's and Vantive's respective growth objectives Represents key milestone in Baxter's ongoing business transformation, enabling heightened strategic clarity, operational efficiency and innovation Baxter shares preliminary outlook for select financial metrics following completion of pending Kidney Care divestiture Baxter International Inc. (NYSE:BAX), a global medtech leader, and funds managed by global

CAIS Platform manager Carlyle to provide insights during CAIS' exclusive alts track at SALT NY CAIS, the leading alternative investment platform, today announced that global investment firm Carlyle (NASDAQ:CG) will be participating in the CAIS Alternative Investments Track at SALT NY. The CAIS alternative investment track at SALT will feature Carlyle and other top-tier managers and investors in several panels including, ‘Impact is Everything, Everything is Impact. From Optional to Essential.' Within the track, advisors will have the opportunity to earn continuing education credits for the Certified Financial Planner (CFP) and Chartered Institute of Management Accounts (CIMA) certification